zip >>> 02210
sector >>> Healthcare
fullTimeEmployees >>> 3082
longBusinessSummary >>> Alexion Pharmaceuticals, Inc. develops and commercializes various therapeutic products. The company offers ULTOMIRIS (ALXN1210/ravulizumab-cwvz), a C5 inhibitor for the treatment of paroxysmal nocturnal hemoglobinuria (PNH) and atypical hemolytic uremic syndrome (aHUS); and SOLIRIS (eculizumab), a monoclonal antibody for the treatment of PNH, aHUS, generalized myasthenia gravis (gMG), and neuromyelitis optica spectrum disorder (NMOSD). It also provides Strensiq (asfotase alfa), a targeted enzyme replacement therapy for patients with hypophosphatasia; and Kanuma (sebelipase alfa) for the treatment of patients with lysosomal acid lipase deficiency. In addition, the company is developing ALXN1210 (Intravenous) that is in Phase III clinical trials for the treatment of gMG and NMOSD; ALXN1210 (Subcutaneous), which is in Phase III clinical trials for PNH and aHUS; ALXN1810 (Subcutaneous) that is in Phase I clinical trial for renal diseases; and ALXN1720 (Subcutaneous), which is in Phase I clinical trial for the treatment of disease states involving dysregulated terminal complement activity. Further, it is developing ALXN1840 (WTX101) that is in Phase III clinical trials for the treatment of Wilson disease; and ALXN1830 and ABY-039, which are in Phase I clinical trials for neonatal Fc receptor. The company serves distributors, pharmacies, hospitals, hospital buying groups, and other healthcare providers in the United States and internationally. Alexion Pharmaceuticals, Inc. has collaboration and license agreement with Halozyme Therapeutics, Inc.; collaborations with Caelum Biosciences, Inc., Dicerna Pharmaceuticals, Inc. and Zealand Pharma A/S; strategic agreement with Caelum Biosciences, Inc.; agreement with Stealth BioTherapeutics Corp.; and a partnership with Affibody AB. The company was founded in 1992 and is headquartered in Boston, Massachusetts.
city >>> Boston
phone >>> 475 230 2596
state >>> MA
country >>> United States
companyOfficers >>> []
website >>> http://www.alexion.com
maxAge >>> 1
address1 >>> 121 Seaport Boulevard
fax >>> 203 271 8198
industry >>> Biotechnology
previousClose >>> 112.02
regularMarketOpen >>> 111.19
twoHundredDayAverage >>> 104.29237
trailingAnnualDividendYield >>> None
payoutRatio >>> 0
volume24Hr >>> None
regularMarketDayHigh >>> 114.9399
navPrice >>> None
averageDailyVolume10Day >>> 2374071
totalAssets >>> None
regularMarketPreviousClose >>> 112.02
fiftyDayAverage >>> 107.94324
trailingAnnualDividendRate >>> None
open >>> 111.19
toCurrency >>> None
averageVolume10days >>> 2374071
expireDate >>> None
yield >>> None
algorithm >>> None
dividendRate >>> None
exDividendDate >>> None
beta >>> 1.395206
circulatingSupply >>> None
startDate >>> None
regularMarketDayLow >>> 109.93
priceHint >>> 2
currency >>> USD
trailingPE >>> 30.049894
regularMarketVolume >>> 1704565
lastMarket >>> None
maxSupply >>> None
openInterest >>> None
marketCap >>> 25079965696
volumeAllCurrencies >>> None
strikePrice >>> None
averageVolume >>> 1888287
priceToSalesTrailing12Months >>> 4.5296865
dayLow >>> 109.93
ask >>> 114.46
ytdReturn >>> None
askSize >>> 800
volume >>> 1704565
fiftyTwoWeekHigh >>> 121.5
forwardPE >>> 9.379508
fromCurrency >>> None
fiveYearAvgDividendYield >>> None
fiftyTwoWeekLow >>> 72.67
bid >>> 114.45
tradeable >>> False
dividendYield >>> None
bidSize >>> 1100
dayHigh >>> 114.9399
exchange >>> NMS
shortName >>> Alexion Pharmaceuticals, Inc.
longName >>> Alexion Pharmaceuticals, Inc.
exchangeTimezoneName >>> America/New_York
exchangeTimezoneShortName >>> EDT
isEsgPopulated >>> False
gmtOffSetMilliseconds >>> -14400000
quoteType >>> EQUITY
symbol >>> ALXN
messageBoardId >>> finmb_347983
market >>> us_market
annualHoldingsTurnover >>> None
enterpriseToRevenue >>> 4.524
beta3Year >>> None
profitMargins >>> 0.15281
enterpriseToEbitda >>> 8.604
52WeekChange >>> 0.16836834
morningStarRiskRating >>> None
forwardEps >>> 12.2
revenueQuarterlyGrowth >>> None
sharesOutstanding >>> 219172992
fundInceptionDate >>> None
annualReportExpenseRatio >>> None
bookValue >>> 47.881
sharesShort >>> 4839839
sharesPercentSharesOut >>> 0.0221
fundFamily >>> None
lastFiscalYearEnd >>> 1577750400
heldPercentInstitutions >>> 0.95391
netIncomeToCommon >>> 846099968
trailingEps >>> 3.808
lastDividendValue >>> None
SandP52WeekChange >>> 0.108078
priceToBook >>> 2.3898833
heldPercentInsiders >>> 0.0029699998
nextFiscalYearEnd >>> 1640908800
mostRecentQuarter >>> 1593475200
shortRatio >>> 3
sharesShortPreviousMonthDate >>> 1596153600
floatShares >>> 218557107
enterpriseValue >>> 25046763520
threeYearAverageReturn >>> None
lastSplitDate >>> 1306108800
lastSplitFactor >>> 2:1
legalType >>> None
morningStarOverallRating >>> None
earningsQuarterlyGrowth >>> None
dateShortInterest >>> 1598832000
pegRatio >>> 0.86
lastCapGain >>> None
shortPercentOfFloat >>> 0.023
sharesShortPriorMonth >>> 4406070
category >>> None
fiveYearAverageReturn >>> None
regularMarketPrice >>> 111.19
logo_url >>> https://logo.clearbit.com/alexion.com
